live, attenuated, double-deleted listeria monocytogenes

Vaccineexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started May 2, 2017 (NCT03189030)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • live, attenuated, double-deleted listeria monocytogenes

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03189030Phase 1May 2, 2017Aduro BioTech
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Aduro BioTechFor profit1112017
1 organizations
Page 1 / 1